Péptido C (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Péptido C" in Galician language version.

refsWebsite

Global rank Galician rank

14doi.org

2^nd place

7^th place

13nih.gov

4^th place

6^th place

5springer.com

274^th place

251^st place

3archive.org

6^th place

8^th place

1xconomy.com

low place

1fiercebiotech.com

low place

archive.org

Sima AA, Zhang W, Sugimoto K, et al. (July 2001). "C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat". Diabetologia 44 (7): 889–97. PMID 11508275. doi:10.1007/s001250100570.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Sjöquist M (October 2001). "Effects of C-peptide on glomerular and renal size and renal function in diabetic rats". Kidney Int. 60 (4): 1258–65. PMID 11576340. doi:10.1046/j.1523-1755.2001.00964.x.
Clark PM (1999). "Assays for insulin, proinsulin and C-peptide". Ann Clin Biochem 36: 541–564.

doi.org

dx.doi.org

Steiner D.F.; Cunningham D.; Spigelman L.; Aten B. (1967). "Insulin Biosynthesis: Evidence for a Precursor". Science 157 (3789): 697–700. PMID 4291105. doi:10.1126/science.157.3789.697.
Hills CE, Brunskill NJ (2008). "Intracellular signalling by C-peptide". Exp Diabetes Res 2008: 635158. PMC 2276616. PMID 18382618. doi:10.1155/2008/635158.
Sima AA, Zhang W, Sugimoto K, et al. (July 2001). "C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat". Diabetologia 44 (7): 889–97. PMID 11508275. doi:10.1007/s001250100570.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Sjöquist M (October 2001). "Effects of C-peptide on glomerular and renal size and renal function in diabetic rats". Kidney Int. 60 (4): 1258–65. PMID 11576340. doi:10.1046/j.1523-1755.2001.00964.x.
Samnegård B, Jacobson SH, Jaremko G, et al. (March 2005). "C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats". Nephrol. Dial. Transplant. 20 (3): 532–8. PMID 15665028. doi:10.1093/ndt/gfh683.
Nordquist L, Brown R, Fasching A, Persson P, Palm F (November 2009). "Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption". Am. J. Physiol. Renal Physiol. 297 (5): F1265–72. PMC 2781335. PMID 19741019. doi:10.1152/ajprenal.00228.2009.
Nordquist L, Wahren J (2009). "C-Peptide: the missing link in diabetic nephropathy?". Rev Diabet Stud 6 (3): 203–10. PMC 2827272. PMID 20039009. doi:10.1900/RDS.2009.6.203.
Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M (August 2008). "Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway". Diabetologia 51 (8): 1534–43. PMID 18493738. doi:10.1007/s00125-008-1032-x.
Mughal RS, Scragg JL, Lister P, et al. (August 2010). "Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein". Diabetologia 53 (8): 1761–71. PMC 2892072. PMID 20461358. doi:10.1007/s00125-010-1736-6.
Jones AG, Hattersley AT (Jul 2013). "The clinical utility of C-peptide measurement in the care of patients with diabetes". Diabetic Medicine 30 (7): 803–17. PMC 3748788. doi:10.1111/dme.12159.
Shapiro ET, Tillil H, Rubenstein AH, Polonsky KS (Nov 1988). "Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration". J Clin Endocrinol Metab 67 (5): 1094–9. doi:10.1210/jcem-67-5-1094.
R, Chandini; Udayabhaskaran V; Binoy J Paul; K.P Ramamoorthy (July 2013). "A study of non-obese diabetes mellitus in adults in a tertiary care hospital in Kerala, India". International Journal of Diabetes in Developing Countries 33 (2): 83–85. doi:10.1007/s13410-013-0113-7. Consultado o 30 March 2014.
Brunskill, NJ (19 September 2016). "C-peptide and diabetic kidney disease.". Journal of internal medicine. PMID 27640884. doi:10.1111/joim.12548.
Shaw, JA; Shetty, P; Burns, KD; Fergusson, D; Knoll, GA (2015). "C-peptide as a Therapy for Kidney Disease: A Systematic Review and Meta-Analysis.". PLOS ONE 10 (5): e0127439. PMC 4439165. PMID 25993479. doi:10.1371/journal.pone.0127439.

fiercebiotech.com

Garde, Damian (February 24, 2015). "Cebix hangs it up after raising $50M for diabetes drug". FierceBiotech.

nih.gov

ncbi.nlm.nih.gov

Steiner D.F.; Cunningham D.; Spigelman L.; Aten B. (1967). "Insulin Biosynthesis: Evidence for a Precursor". Science 157 (3789): 697–700. PMID 4291105. doi:10.1126/science.157.3789.697.
Hills CE, Brunskill NJ (2008). "Intracellular signalling by C-peptide". Exp Diabetes Res 2008: 635158. PMC 2276616. PMID 18382618. doi:10.1155/2008/635158.
Sima AA, Zhang W, Sugimoto K, et al. (July 2001). "C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat". Diabetologia 44 (7): 889–97. PMID 11508275. doi:10.1007/s001250100570.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Sjöquist M (October 2001). "Effects of C-peptide on glomerular and renal size and renal function in diabetic rats". Kidney Int. 60 (4): 1258–65. PMID 11576340. doi:10.1046/j.1523-1755.2001.00964.x.
Samnegård B, Jacobson SH, Jaremko G, et al. (March 2005). "C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats". Nephrol. Dial. Transplant. 20 (3): 532–8. PMID 15665028. doi:10.1093/ndt/gfh683.
Nordquist L, Brown R, Fasching A, Persson P, Palm F (November 2009). "Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption". Am. J. Physiol. Renal Physiol. 297 (5): F1265–72. PMC 2781335. PMID 19741019. doi:10.1152/ajprenal.00228.2009.
Nordquist L, Wahren J (2009). "C-Peptide: the missing link in diabetic nephropathy?". Rev Diabet Stud 6 (3): 203–10. PMC 2827272. PMID 20039009. doi:10.1900/RDS.2009.6.203.
Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M (August 2008). "Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway". Diabetologia 51 (8): 1534–43. PMID 18493738. doi:10.1007/s00125-008-1032-x.
Mughal RS, Scragg JL, Lister P, et al. (August 2010). "Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein". Diabetologia 53 (8): 1761–71. PMC 2892072. PMID 20461358. doi:10.1007/s00125-010-1736-6.
Jones AG, Hattersley AT (Jul 2013). "The clinical utility of C-peptide measurement in the care of patients with diabetes". Diabetic Medicine 30 (7): 803–17. PMC 3748788. doi:10.1111/dme.12159.
Brunskill, NJ (19 September 2016). "C-peptide and diabetic kidney disease.". Journal of internal medicine. PMID 27640884. doi:10.1111/joim.12548.
Shaw, JA; Shetty, P; Burns, KD; Fergusson, D; Knoll, GA (2015). "C-peptide as a Therapy for Kidney Disease: A Systematic Review and Meta-Analysis.". PLOS ONE 10 (5): e0127439. PMC 4439165. PMID 25993479. doi:10.1371/journal.pone.0127439.

pubchem.ncbi.nlm.nih.gov

C-Peptide - Compound Summary, PubChem.

springer.com

adisinsight.springer.com

"C-peptide - Creative Peptides -". AdisInsight. Consultado o 22 October 2016.
"C-peptide - Eli Lilly". AdisInsight. Consultado o 22 October 2016.
"C-peptide long-acting - Cebix". adisinsight.springer.com. AdisInsight. Consultado o 22 October 2016.

link.springer.com

J. Wahren, K. Ekberg, H. Jörnvall. C-peptide is a bioactive peptide. Diabetologia. March 2007, 50:503. [1]
R, Chandini; Udayabhaskaran V; Binoy J Paul; K.P Ramamoorthy (July 2013). "A study of non-obese diabetes mellitus in adults in a tertiary care hospital in Kerala, India". International Journal of Diabetes in Developing Countries 33 (2): 83–85. doi:10.1007/s13410-013-0113-7. Consultado o 30 March 2014.

xconomy.com

Bigelow, Bruce V. (23 February 2015). "Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug". Xconomy.